The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

For patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated w ...

A doctor has shared some advice about eating bananas, warning that many of us could be missing out on a whole host of health ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Discover the alarming link between weight and stroke risk, plus expert-recommended strategies that could protect your brain ...

From innovative therapy approaches to emotional healing, discover how stroke survivors are reclaiming their independence through rehabilitation methods.

A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely ...

DONCASTER and Bassetlaw Teaching Hospitals has been named as one of just four NHS sites in England selected to test a new ...

Professor Martin James has been recognised nationally for his pioneering stroke research, including AI-driven treatments and ...

Artificial intelligence is revolutionizing stroke management by improving diagnosis, accelerating treatment, enabling remote ...